Brief: Brickell Biotech Posts Q1 Loss Per Share Of $0.15

Fresh Tracks Therapeutics

13/05/2021 22:22

May 13 (Reuters) - Brickell Biotech Inc  BBI.O :
    * BRICKELL BIOTECH REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * BRICKELL BIOTECH INC - TOPLINE RESULTS FOR PHASE 3 PIVOTAL
CARDIGAN I AND CARDIGAN II STUDIES EXPECTED IN Q4 2021
    * BRICKELL BIOTECH INC - QTRLY NET LOSS PER COMMON SHARE
ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC AND DILUTED $0.15

Source text for Eikon:  ID:nGNX9qBMdJ 
Further company coverage:  BBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))